Literature DB >> 215414

Facilitation of cardiac sympathetic function by angiotensin II: role of presynaptic angiotensin receptors.

M F Lokhandwala, E Amelang, J P Buckley.   

Abstract

Intravenous infusion of two separate doses of angiotensin II in pentobarbital-anesthetized, desipramine-treated animals produced dose-related increases in arterial blood pressure and caused significant potentiation of the cardioacceleration observed during the stimulation of the right postganglionic cardiac sympathetic nerve fibers. Positive chronotropic effects of intravenous norepinephrine were not altered during angiotensin II infusion. Prior administration of Saralasin, an angiotensin receptor antagonist, caused significant attenuation of the pressor action of angiotensin II, and also significantly antagonized the facilitatory effect of angiotensin II on sympathetic transmission to the myocardium. These results suggest that angiotensin II can cause facilitation of sympathetic nerve function to the myocardium via an action on angiotensin receptors which may be located on sympathetic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215414     DOI: 10.1016/0014-2999(78)90299-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac beta 1-adrenoceptors.

Authors:  J T Knape; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

2.  Angiotensin II-noradrenergic interactions in renovascular hypertensive rats.

Authors:  J B Zimmerman; D Robertson; E K Jackson
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

3.  Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo.

Authors:  Jaroslav Pavel; Julius Benicky; Yuki Murakami; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.